Chapter 74 Constipation and Anorectal Diseases
The presenting signs of anorectal disease can include any of the following: dyschezia, hematochezia, constipation, anal discomfort (licking, scooting), ribbon-like feces, fecal incontinence, anal discharge, malodorous perineum, matting of perianal hair, and perianal dermatitis. Physical examination establishes the diagnosis of anorectal disease in most cases. In many anorectal diseases, surgery is required for effective treatment (see Chapter 75).
CONSTIPATION
Etiology
Underlying causes and predisposing factors for constipation are listed in Table 74-1 and include dietary factors, environmental factors, painful defecation, anorectal or colonic obstruction, neuromuscular diseases, fluid and electrolyte disturbances, and drug-related effects.
Category | Cause | |
---|---|---|
Dietary factors | Ingested foreign material mixed with feces (hair, bones, cloth, garbage, cat litter, stones, wood, plant material) | |
Inadequate water intake | ||
Environmental/psychological factors | Dirty litter box | |
Prolonged inactivity | ||
Confinement (hospitalization, boarding) | ||
Change in habitat or daily routine | ||
Painful defecation | Anorectal disorders | |
Anal sac impaction, infection, or abscess | ||
Anorectal stricture, tumor, or foreign body | ||
Myiasis | ||
Perianal fistulae | ||
Perianal bite wound cellulitis or abscess | ||
Pseudocoprostasis | ||
Orthopedic disorders | ||
Spinal disease or injury | ||
Injuries of the pelvis, hip joints, or pelvic limbs | ||
Rectocolonic obstruction | Extramural | |
Prostatic hypertrophy, tumor, abscess, or prostatitis | ||
Paraprostatic cyst | ||
Pelvic fracture (malunion) | ||
Pelvic collapse due to nutritional bone disease | ||
Perianal tumor | ||
Pseudocoprostasis | ||
Intramural or intraluminal | ||
Rectocolonic stricture, tumor, or foreign body | ||
Perineal hernia or rectal diverticulum | ||
Rectal prolapse | ||
Fecalith | ||
Neuromuscular dysfunction | Lumbosacral spinal cord disease (injury, deformity, degeneration, neoplasia) | |
Bilateral pelvic nerve injury | ||
Dysautonomia (Key-Gaskell syndrome) | ||
Hypothyroidism | ||
Idiopathic megacolon | ||
Fluid and electrolyte abnormalities | Dehydration (e.g., chronic renal disease) | |
Hypokalemia | ||
Hypercalcemia (hyperparathyroidism, etc.) | ||
Drug-induced effects | Anticholinergics | |
Adrenergic antagonists | ||
Calcium channel blockers | ||
Phenothiazines and benzodiazepines | ||
Opiates and opioids | ||
Diuretics | ||
Antihistamines | ||
Aluminum hydroxide antacids | ||
Sucralfate | ||
Kaolin-pectin | ||
Barium sulfate | ||
Iron | ||
Laxatives (abuse or chronic overuse) |
Neuromuscular Disease
Neuromuscular disorders may lead to constipation by interfering with colonic innervation or smooth muscle function or with the ability of the animal to assume the normal defecation stance. For example, this may occur in association with disease or injury of the lumbosacral spinal cord (canine intervertebral disc disease), spinal deformity (e.g., Manx cats), endocrine disease (hypothyroidism), and dysautonomia, a progressive fatal autonomic polyneuropathy. When innervation of the anus is also impaired, fecal incontinence may be an associated clinical sign.
Fluid and Electrolyte Disorders
Dehydration can cause the feces to become excessively dry and hard, predisposing the animal to constipation. Hypokalemia and hypercalcemia can impair colonic smooth muscle function. A combination of these may explain the frequent constipation seen in chronic renal failure, especially in cats.
Clinical Signs
Diagnosis
The presence of constipation usually is determined from the history and confirmed by rectal and abdominal palpation of colonic distention with hard, impacted feces. The goal of diagnosis is to identify predisposing factors (see Table 74-1).
History
Question the owner to identify the potential dietary, environmental, behavioral, psychological, and medication-related factors or predispositions listed in Table 74-1.
Physical Examination
Routine Laboratory Evaluations
Abdominal Radiography
Perform abdominal radiography to determine the following:
Other Diagnostic Evaluations
These diagnostics may be warranted in selected patients with recurrent constipation:
Treatment Overview
Initial Relief of Constipation
Rectal Suppositories
To promote defecation in patients with mild constipation, give one to three pediatric rectal suppositories of docusate, glycerin, or bisacodyl. Rectal suppositories can be used alone or in combination with an oral laxative (Table 74-2). Pet and owner compliance are often limiting factors with suppositories.
Treatment | Product (Manufacturer) | Dosage Regimen |
---|---|---|
Oral Laxatives | ||
Bulk-Forming Laxatives | ||
Psyllium | Metamucil (Searle) | 1–5tsp daily with food |
Unprocessed whole grain and bran cereal | Fiber One (General Mills) and others | 1–5tbsp daily with food |
Canned pumpkin | Pie filling (Libby) | 1–5tbsp daily with food |
Commercial high-fiber diet | Many | Use as daily food source |
Lubricant Laxatives | ||
White petrolatum | Laxatone (Evsco) | 1–5 ml daily PO |
Mineral oil* | Many | Not recommended |
Emollient Laxatives | ||
Docusate sodium | Colace (Shire) | Cat: 50 mg daily PO |
Dog: 50–200 mg daily PO | ||
Docusate calcium | Surfak (Geneva) | Cat: 50–100 mg daily PO |
Dog: 100–240 mg daily PO | ||
Osmotic Laxatives | ||
Lactulose | Duphalac Syrup (Reid-Powell), Cephulac (Marion Merrell Dow) | 0.5–1.0 ml/kg q8–12h PO |
Magnesium hydroxide | Phillips Milk of Magnesia (Glenbrook) | 2–8 tablets daily PO |
Polyethylene glycol and electrolytes† | Colyte (Schwarz), GoLytely (Braintree) | 25–40 ml/kg PO, repeat in 2–4 hours (for bowel prep) |
Stimulant Laxatives | ||
Bisacodyl | Dulcolax (Boehringer Ingelheim) | Cat: 5 mg daily PO |
Dog: 5–20 mg daily PO | ||
Senna | Senokot (Purdue Frederick) | 1–4 tablets q12–24h PO |
Castor oil† | Many | 5–30 ml PO (bowel prep) |
Promotility Drugs | ||
Cisapride | Compounded pharmaceutical | Cat: 1.0 mg/kg q8h or 1.5 mg/kg q12h PO |
Dog: 0.25–0.5 mg/kg q8–12h PO | ||
Tegaserod | Zelnorm (Novartis) | 0.05–0.1 mg/kg q12h PO |
Ranitidine | Zantac (Glaxo) | Cat: 3.5 mg/kg q12h PO |
Dog: 2.0 mg/kg q12h PO | ||
Nizatidine | Axid (Eli Lilly) | 2.5 mg/kg q24h PO |
Rectal Suppositories | ||
Glycerin | Many | 1–3 pediatric |
Docusate sodium | Colace (Shire) | 1–3 pediatric |
Bisacodyl | Dulcolax (Boehringer Ingelheim) | 1–3 pediatric |
Enemas | ||
Isotonic saline solution (or tap water) | 5–10 ml/kg | |
Lactulose | Duphaloc, Cephulac (see above) | 5–30 ml |
Docusate sodium | Colace (Shire) | 5–30 ml |
Mineral oil | Many | 5–30 ml or 1–2 ml/kg |
Sodium phosphate‡ | Fleet Children’s Enema (Fleet) | 1–2 ml/kg or 1 enema unit |
Bisacodyl | Fleet Bisacodyl Enema (Fleet) | 1–2 ml/kg or 1 enema unit |
* Caution: May cause lipid aspiration pneumonia and may interfere with absorption of fat-soluble vitamins; combination with docusate may cause undesirable absorption of mineral oil.
† Used mainly to prepare the colon for radiography or endoscopy.
‡ Do not use in cats or small dogs.
Enema Therapy
Enema solutions are used to soften hard, impacted feces and promote evacuation. Warm the enema solution prior to instillation and use a lubricated rubber catheter or feeding tube to administer the calculated dose slowly so as not to induce vomiting. Commonly used enema solutions (see Table 74-2) include the following: